13 December 2024
We are a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system.
13 December 2024
Newron is committed to providing reliable and transparent information about our business in an open and timely manner. This area contains investment and shareholder information, key financial data and presentations and webcasts.